Bridge City Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Bridge City Capital's AMPH Position: Q3 2026 in Review
Bridge City Capital increased its Amphastar Pharmaceuticals (AMPH) stake by 13% in Q3 2026, buying an estimated $977K and bringing the position to 383,901 shares worth $9.9M. The position accounts for 2.07% of the portfolio, ranked #6.
Bridge City Capital first reported a position in AMPH in Q2 2023 and has held it in 14 quarters since. 59 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Bridge City Capital held 383,901 shares of Amphastar Pharmaceuticals worth $9.9M as of Q3 2026.
- Bridge City Capital bought 45,193 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $977K.
- Amphastar Pharmaceuticals made up 2.07% of Bridge City Capital's portfolio in Q3 2026, its #6 holding.
- Bridge City Capital first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
- 59 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Bridge City Capital's 13F filing for Q3 2026, filed 29 Oct 2026.